These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 30374033)

  • 1. Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease.
    Rodríguez-Ortiz ME; Pontillo C; Rodríguez M; Zürbig P; Mischak H; Ortiz A
    Sci Rep; 2018 Oct; 8(1):15940. PubMed ID: 30374033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A urinary proteome-based classifier for the early detection of decline in glomerular filtration.
    Pontillo C; Jacobs L; Staessen JA; Schanstra JP; Rossing P; Heerspink HJL; Siwy J; Mullen W; Vlahou A; Mischak H; Vanholder R; Zürbig P; Jankowski J
    Nephrol Dial Transplant; 2017 Sep; 32(9):1510-1516. PubMed ID: 27387473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.
    Critselis E; Lambers Heerspink H
    Nephrol Dial Transplant; 2016 Feb; 31(2):249-54. PubMed ID: 25791724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary peptidomic biomarkers of renal function in heart transplant recipients.
    Huang QF; Zhang ZY; Van Keer J; Trenson S; Nkuipou-Kenfack E; Yang WY; Thijs L; Vanhaecke J; Van Aelst LNL; Van Cleemput J; Janssens S; Verhamme P; Mischak H; Staessen JA
    Nephrol Dial Transplant; 2019 Aug; 34(8):1336-1343. PubMed ID: 29982668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial.
    Tofte N; Lindhardt M; Adamova K; Bakker SJL; Beige J; Beulens JWJ; Birkenfeld AL; Currie G; Delles C; Dimos I; Francová L; Frimodt-Møller M; Girman P; Göke R; Havrdova T; Heerspink HJL; Kooy A; Laverman GD; Mischak H; Navis G; Nijpels G; Noutsou M; Ortiz A; Parvanova A; Persson F; Petrie JR; Ruggenenti PL; Rutters F; Rychlík I; Siwy J; Spasovski G; Speeckaert M; Trillini M; Zürbig P; von der Leyen H; Rossing P;
    Lancet Diabetes Endocrinol; 2020 Apr; 8(4):301-312. PubMed ID: 32135136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CKD273, a new proteomics classifier assessing CKD and its prognosis.
    Argilés Á; Siwy J; Duranton F; Gayrard N; Dakna M; Lundin U; Osaba L; Delles C; Mourad G; Weinberger KM; Mischak H
    PLoS One; 2013; 8(5):e62837. PubMed ID: 23690958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The urinary proteomics classifier chronic kidney disease 273 predicts cardiovascular outcome in patients with chronic kidney disease.
    Verbeke F; Siwy J; Van Biesen W; Mischak H; Pletinck A; Schepers E; Neirynck N; Magalhães P; Pejchinovski M; Pontillo C; Lichtinghagen R; Brand K; Vlahou A; De Bacquer D; Glorieux G
    Nephrol Dial Transplant; 2021 Apr; 36(5):811-818. PubMed ID: 31837226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.
    Currie GE; von Scholten BJ; Mary S; Flores Guerrero JL; Lindhardt M; Reinhard H; Jacobsen PK; Mullen W; Parving HH; Mischak H; Rossing P; Delles C
    Cardiovasc Diabetol; 2018 Apr; 17(1):50. PubMed ID: 29625564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The urinary proteome as correlate and predictor of renal function in a population study.
    Gu YM; Thijs L; Liu YP; Zhang Z; Jacobs L; Koeck T; Zürbig P; Lichtinghagen R; Brand K; Kuznetsova T; Olivi L; Verhamme P; Delles C; Mischak H; Staessen JA
    Nephrol Dial Transplant; 2014 Dec; 29(12):2260-8. PubMed ID: 24981581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.
    Zewinger S; Rauen T; Rudnicki M; Federico G; Wagner M; Triem S; Schunk SJ; Petrakis I; Schmit D; Wagenpfeil S; Heine GH; Mayer G; Floege J; Fliser D; Gröne HJ; Speer T
    J Am Soc Nephrol; 2018 Nov; 29(11):2722-2733. PubMed ID: 30279273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.
    Schanstra JP; Zürbig P; Alkhalaf A; Argiles A; Bakker SJ; Beige J; Bilo HJ; Chatzikyrkou C; Dakna M; Dawson J; Delles C; Haller H; Haubitz M; Husi H; Jankowski J; Jerums G; Kleefstra N; Kuznetsova T; Maahs DM; Menne J; Mullen W; Ortiz A; Persson F; Rossing P; Ruggenenti P; Rychlik I; Serra AL; Siwy J; Snell-Bergeon J; Spasovski G; Staessen JA; Vlahou A; Mischak H; Vanholder R
    J Am Soc Nephrol; 2015 Aug; 26(8):1999-2010. PubMed ID: 25589610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the chronic kidney disease urinary proteomic predictor CKD273 with clinical risk factors of graft failure in kidney allograft recipients.
    Rambabova-Bushljetik I; Metzger J; Siwy J; Dohcev S; Bushljetikj O; Filipce V; Trajceska L; Mischak H; Spasovski G
    Nephrol Dial Transplant; 2022 Sep; 37(10):2014-2021. PubMed ID: 34634117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.
    Ju W; Nair V; Smith S; Zhu L; Shedden K; Song PXK; Mariani LH; Eichinger FH; Berthier CC; Randolph A; Lai JY; Zhou Y; Hawkins JJ; Bitzer M; Sampson MG; Thier M; Solier C; Duran-Pacheco GC; Duchateau-Nguyen G; Essioux L; Schott B; Formentini I; Magnone MC; Bobadilla M; Cohen CD; Bagnasco SM; Barisoni L; Lv J; Zhang H; Wang HY; Brosius FC; Gadegbeku CA; Kretzler M;
    Sci Transl Med; 2015 Dec; 7(316):316ra193. PubMed ID: 26631632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albuminuria during treatment with angiotensin type II receptor blocker is a predictor for GFR decline among non-diabetic hypertensive CKD patients.
    Yu MY; Kim DK; Park JH; Shin SJ; Lee SH; Choi BS; Lim CS; Chin HJ
    PLoS One; 2018; 13(8):e0202676. PubMed ID: 30148871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical component quality of life reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 quality of life: An AusDiab analysis.
    Wong MG; Ninomiya T; Liyanage T; Sukkar L; Hirakawa Y; Wang Y; Wyld MLR; Morton RL; Chadban S; Howard K; Jardine MJ
    Nephrology (Carlton); 2019 Jun; 24(6):605-614. PubMed ID: 30039893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population.
    Guessous I; McClellan W; Kleinbaum D; Vaccarino V; Hugues H; Boulat O; Marques-Vidal P; Paccaud F; Theler JM; Gaspoz JM; Burnier M; Waeber G; Vollenweider P; Bochud M
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1162-9. PubMed ID: 25901090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.
    Nkuipou-Kenfack E; Duranton F; Gayrard N; Argilés À; Lundin U; Weinberger KM; Dakna M; Delles C; Mullen W; Husi H; Klein J; Koeck T; Zürbig P; Mischak H
    PLoS One; 2014; 9(5):e96955. PubMed ID: 24817014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
    Penno G; Russo E; Garofolo M; Daniele G; Lucchesi D; Giusti L; Sancho Bornez V; Bianchi C; Dardano A; Miccoli R; Del Prato S
    Diabetologia; 2017 Jun; 60(6):1102-1113. PubMed ID: 28357502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.